SRZN vs TECX: stock comparison and AI forecast
Surrozen, Inc./De (SRZN) and Tectonic Therapeutic, Inc. (TECX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
SRZN Surrozen, Inc./De
- Price
- $31.00 +5.9% · 6M
- Market Cap
- $542M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
TECX Tectonic Therapeutic, Inc.
- Price
- $20.64 -25.0% · 6M
- Market Cap
- $404M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- SRZN is 1.3 times larger than TECX by market capitalization ($542M against $404M).
- Over the last six months SRZN returned +5.9% and TECX -25.0%.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | SRZN | TECX |
|---|---|---|
| Market Cap | $542M | $404M |
| P/B Ratio | – | 1.76x |
| EPS | $-39.55 | $-5.56 |
| Book Value/Share | – | $11.73 |
| Revenue/Share | $0.66 | – |
| FCF/Share | $-2.00 | $-3.55 |
Profitability & Margins
| Metric | SRZN | TECX |
|---|---|---|
| ROE | – | -38.4% |
| ROA | – | -36.1% |
| ROIC | -41.6% | -41.6% |
| Operating Margin | -385.3% | – |
| EBT Margin | -2122.2% | – |
| Tax Rate | 0.0% | -0.4% |
Financial Health
| Metric | SRZN | TECX |
|---|---|---|
| Current Ratio | 12.14x | 19.71x |
| D/E Ratio | – | 0.06x |
| Financial Leverage | – | 1.06x |
| Interest Coverage | -456.8x | 1728.7x |
| Working Capital | $100M | $226M |
Cash Flow
| Metric | SRZN | TECX |
|---|---|---|
| Operating Cash Flow | -$35M | -$69M |
| Free Cash Flow | -$35M | -$69M |
| Capital Spending | -$220K | -$100K |
| FCF/Sales | -303.9% | – |
| CapEx/Sales | 1.9% | – |
Operational Efficiency
| Metric | SRZN | TECX |
|---|---|---|
| Asset Turnover | 0.10x | – |
| Receivables Turnover | 2.3x | – |
| Fixed Assets Turnover | 25.2x | – |
| Days Sales Outstanding | 159 days | – |
| Payables Period | – | -4 days |
Income Statement
| Metric | SRZN | TECX |
|---|---|---|
| Total Revenue | $12M | – |
| Operating Income | -$44M | -$96M |
| Net Income | – | -$88M |
| R&D Expense | $35M | $73M |
| Cost of Goods Sold | – | -$152M |
Dividend & Shareholder Information
| Metric | SRZN | TECX |
|---|---|---|
| Shares Outstanding | 18M | 20M |
SRZN vs TECX: stock comparison and AI forecast
Which is bigger, SRZN or TECX?
SRZN is 1.3 times larger than TECX by market capitalization ($542M against $404M).
Which stock performed better over the last six months, SRZN or TECX?
Over the last six months SRZN returned +5.9% and TECX -25.0%.
Which one does Intratio's AI model rank higher, SRZN or TECX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.